| Rank | Clinic Name | Patient Rating | Country | Lead Doctor | experience | Techniques | Best For | Why It’s Ranked | Accreditations |
|---|---|---|---|---|---|---|---|---|---|
| #1 | — / 5 | Shanghai, China | 23+ years | Brain MRI, MRI of one area | Refractory or relapsed blood cancers | Over 1,500 CAR-T infusions performed since 2014, with an 87.5% complete remission rate for lymphoma. Offers CAR-NK and epigenetic immunotherapy, coordinated by a multidisciplinary tumor board. | — | ||
| #2 | 4.5 / 5 | Chengdu, China | 35+ years100,000+ treatments | Immune checkpoint inhibitors, biomarker-based stratification | Advanced or treatment-resistant solid tumors | — | — | ||
| #3 | 3.0 / 5 (1) | Beijing, China | — | — | Immunotherapy | — | — | — | |
| #4 | 4.6 / 5 (19) | Guangzhou, China | 30+ years | Combined immunotherapy for cancer (CIC), DC-CIK immunotherapy, FoundationOne CDx testing | Stage 3–4 cancer after ineffective chemo or radiation | NK cell therapy expands 80 mL of patient blood into 8–10 billion cells; FoundationOne CDx reads 324 genes to match treatment. JCI-accredited, with 7 published immunotherapy studies. | — | ||
| #5 | — / 5 | Qionghai, China | 20+ years | Immunotherapy, CT (computer tomography) | — | — | — | ||
| #6 | 5.0 / 5 | Hainan Province, China | — | — | Immunotherapy | — | — | Joint Commission International |